VLCAD deficiency: Pitfalls in newborn screening and confirmation of diagnosis by mutation analysis
- 30 June 2006
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 88 (2) , 166-170
- https://doi.org/10.1016/j.ymgme.2005.12.012
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Tissue Carnitine Homeostasis in Very-Long-Chain Acyl-CoA Dehydrogenase–Deficient MicePediatric Research, 2005
- Age-Related Variations in Acylcarnitine and Free Carnitine Concentrations Measured by Tandem Mass SpectrometryClinical Chemistry, 2005
- Normal acylcarnitine levels during confirmation of abnormal newborn screening in long‐chain fatty acid oxidation defectsJournal of Inherited Metabolic Disease, 2004
- MS/MS-based newborn and family screening detects asymptomatic patients with very-long-chain acyl-CoA dehydrogenase deficiencyThe Journal of Pediatrics, 2003
- Screening Newborns for Inborn Errors of Metabolism by Tandem Mass SpectrometryNew England Journal of Medicine, 2003
- Tandem Mass Spectrometric Analysis for Amino, Organic, and Fatty Acid Disorders in Newborn Dried Blood SpotsClinical Chemistry, 2001
- Molecular Heterogeneity in Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency Causing Pediatric Cardiomyopathy and Sudden DeathCirculation, 1999
- Clear Correlation of Genotype with Disease Phenotype in Very–Long-Chain Acyl-CoA Dehydrogenase DeficiencyAmerican Journal of Human Genetics, 1999
- Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patientsClinica Chimica Acta; International Journal of Clinical Chemistry, 1998
- Diagnosis of Inborn Errors of Metabolism from Blood Spots by Acylcarnitines and Amino Acids Profiling Using Automated Electrospray Tandem Mass SpectrometryPediatric Research, 1995